FTD mutation carriers with higher baseline CSF rejuvenation composite levels demonstrated slower global cognitive and functional declines, and slower plasma NfL increases which approached significance (P = 0.078), relationships that were not evident in clinically normal non-carrier adults (Table 2; Fig. 2; Supplementary Fig. 1). Here, NEFL is linked to frontotemporal dementia.